The Research and Training Core provides professional and non-professional training and outreach programs to publicize the ADRC, improve clinical and research skills related to Alzheimer's disease (AD), and foster interest in AD and related disorders.
Three aims are carried forward from the original granting period to the current proposal. These include: 1) Establishment, provision, and refinement of professional educational programs on AD and related disorders. 2) Establishment, provision, and refinement of annual public educational programs on AD and related disorders. 3) Dissemination and evaluation of current training materials on AD and related disorders. To fulfill these aims, this core will continue to present annual CME programs, public forums, monthly seminars, and lectures on AD and related disorders. Collaborations with the Alzheimer's Association, the Northwest Geriatric Education Center, and other agencies and groups in the greater Seattle-Tacoma, as well as the Washington-Alaska-Montana-Idaho region, will continue so that we can disseminate the current state of clinical and research knowledge to interested parties outside and inside the Center. The core will also continue to disseminate a comprehensive training program on Managing and Understanding Behavior Problems in Alzheimer's Disease and Related Disorders and the quarterly newsletter, Dimensions. Both the training program and the newsletter have been evaluated in prior years and have received awards from professional associations. In addition, a fourth aim is to develop, implement, disseminate and evaluate specialized training programs to underserved populations. Specific attention will now be given to underserved populations that have not fully accessed the training programs thus far presented. Relevant to this geographic region, we will target Asians and Pacific Islanders, and Native Americans. Oral and written materials will be adapted to better suit the needs of these groups and special programs will be advertised and offered to educate and inform the public as well as health care professionals interested in working with these individuals.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005136-16S1
Application #
6216963
Study Section
Project Start
1999-08-15
Project End
2000-04-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Gray, Shelly L; Anderson, Melissa L; Hanlon, Joseph T et al. (2018) Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort. J Alzheimers Dis 65:607-616
Reed, May J; Damodarasamy, Mamatha; Pathan, Jasmine L et al. (2018) Increased Hyaluronan and TSG-6 in Association with Neuropathologic Changes of Alzheimer's Disease. J Alzheimers Dis :
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Suchy-Dicey, Astrid M; Muller, Clemma J; Madhyastha, Tara M et al. (2018) Telomere Length and Magnetic Resonance Imaging Findings of Vascular Brain Injury and Central Brain Atrophy: The Strong Heart Study. Am J Epidemiol 187:1231-1239
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Nafikov, Rafael A; Nato Jr, Alejandro Q; Sohi, Harkirat et al. (2018) Analysis of pedigree data in populations with multiple ancestries: Strategies for dealing with admixture in Caribbean Hispanic families from the ADSP. Genet Epidemiol 42:500-515
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Young, Jessica E; Fong, Lauren K; Frankowski, Harald et al. (2018) Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer's Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein. Stem Cell Reports 10:1046-1058
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827

Showing the most recent 10 out of 753 publications